Abstract Body

The HIV-1 Rev-Rev Response Element (RRE) regulatory axis is required for the nucleocytoplasmic export of intron-containing viral mRNAs, an essential step in viral replication. A viral protein, Rev, binds to the RRE, an RNA structure found on incompletely spliced viral mRNAs, multimerizes, and recruits cellular factors to export the transcript. We previously described two Revs from primary isolates which display markedly different levels of activity. The high-activity, 9-G, and low-activity, 8-G, Revs differ by a total of 29 amino acids spanning across all domains including the bipartite oligomerization domain (OD), arginine rich motif (ARM), and nuclear export site (NES) (see Figure). Here, we define key residues causing differential activity.

Chimeric Revs were generated by exchanging regions between 8-G and 9-G sequences. Rev activity was determined using a recently described assay. Two constructs were created: an HIV vector modified to produce two fluorescent proteins in a Rev-dependent or Rev-independent fashion, and a murine stem cell virus vector producing different Revs and a third fluorescent marker. Both constructs were packaged and used to co-transduce lymphoid cells. Rev activity was determined by measuring relative intensity of the fluorescent markers.

9-G Rev displayed about 4-fold greater activity than 8-G Rev (p=0.001). Chimeric Revs created by exchanging the turn or link, the c-terminus, a block including the ARM and second OD, or the NES did not show changes in functional activity. However, exchanging a block including the n-terminus and the first OD with four amino acid changes (N-OD) was sufficient to determine activity, such that a 9-G N-OD in an 8-G background was as active as unmodified 9-G Rev (p=0.55), and vice versa. A single variation at position 24 was tested as this has been shown to affect activity in NL4-3. The 9-G Q24R mutant had a 50% reduction in activity (p=0.001) but the 8-G R24Q mutant did not show increased activity, demonstrating an additional role for the other three amino acid changes.

The large difference in Rev-RRE activity between these primary isolates is due to four amino acid changes. Some of these residues have been implicated in Rev monomer stabilization while others may affect dimer-dimer interaction. Rev activity changes in another lentivirus are associated with clinical disease progression. Activity variation in HIV Rev may also play a role in clinical disease, such as in the establishment of latency.